DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 210 filers reported holding DIPLOMAT PHARMACY INC in Q2 2018. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $3,249,000 | -23.9% | 663,050 | -5.5% | 0.25% | -19.3% |
| Q2 2019 | $4,272,000 | +5.8% | 701,445 | +0.9% | 0.30% | +3.7% |
| Q1 2019 | $4,037,000 | -100.0% | 694,908 | -0.2% | 0.29% | -61.2% |
| Q4 2018 | $9,374,365,000 | -30.7% | 696,461 | -0.1% | 0.76% | -13.2% |
| Q3 2018 | $13,536,282,000 | -15.8% | 697,387 | +10.9% | 0.87% | -24.9% |
| Q2 2018 | $16,071,770,000 | +25.7% | 628,786 | -0.9% | 1.16% | +21.3% |
| Q1 2018 | $12,790,233,000 | +9.7% | 634,751 | +9.2% | 0.96% | +5.5% |
| Q4 2017 | $11,663,259,000 | +7.6% | 581,129 | +11.0% | 0.91% | -1.4% |
| Q3 2017 | $10,838,496,000 | +1120.6% | 523,346 | +1550.8% | 0.92% | +839.8% |
| Q3 2016 | $887,973,000 | – | 31,702 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empirical Capital Management, LLC | 479,018 | $9,298,000 | 8.38% |
| Rhenman & Partners Asset Management AB | 1,174,411 | $22,795,000 | 2.28% |
| Capital Investment Advisory Services, LLC | 153,842 | $2,986,000 | 1.40% |
| Cortina Asset Management, LLC | 1,238,420 | $24,038,000 | 1.12% |
| Investors Research Corp | 92,027 | $1,786,000 | 1.02% |
| Matarin Capital Management, LLC | 697,387 | $13,536,282,000 | 0.87% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 853,687 | $16,570,000 | 0.59% |
| RICE HALL JAMES & ASSOCIATES, LLC | 809,257 | $15,708,000 | 0.56% |
| BROADVIEW ADVISORS LLC | 156,700 | $3,042,000 | 0.52% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 3,535,217 | $68,619,000 | 0.44% |